Healthcare -
Drug Manufacturers - Specialty & Generic - NYSE - US
$ 6.83
-8.69 %
$ 370 M
Market Cap
-1.75
P/E
EBS - GROSS PROFIT
Gross Profit EBS - Emergent BioSolutions Inc.
344 M
LAST VALUE
-42.36%
2 YEAR CAGR
-5.66%
5 YEAR CAGR
3.21%
10 YEAR CAGR